Associations between air pollution and pediatric eczema, rhinoconjunctivitis and asthma: A meta-analysis of European birth cohorts by Fuertes, E. (Elaine) et al.
Contents lists available at ScienceDirect
Environment International
journal homepage: www.elsevier.com/locate/envint
Associations between air pollution and pediatric eczema, rhinoconjunctivitis
and asthma: A meta-analysis of European birth cohorts
Elaine Fuertesa,b,c,d,⁎, Jordi Sunyerb,c,d,e, Ulrike Gehringf, Daniela Portag, Francesco Forastiereg,
Giulia Cesaronig, Martine Vrijheidb,c,d, Mònica Guxensb,c,d,h, Isabella Annesi-Maesanoi,
Rémy Slamaj, Dieter Maierk, Manolis Kogevinasb,c,d,e, Jean Bousquetl, Leda Chatzim,
Aitana Lertxundid,n,o, Mikel Basterrechead,o,p, Ana Espluguesd,q,r, Amparo Ferrerod,q,
John Wrights, Dan Masons, Rosie McEachans, Judith Garcia-Aymerichb,c,d,
Bénédicte Jacqueminb,c,d,t,u,v
aNational Heart and Lung Institute, Imperial College London, London, United Kingdom
b ISGlobal, Barcelona, Spain
cUniversitat Pompeu Fabra (UPF), Barcelona, Spain
d CIBER Epidemiología y Salud Pública (CIBERESP), Spain
e IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain
f Institute for Risk Assessment Sciences, Utrecht University, Utrecht, Netherlands
g Department of Epidemiology, Lazio Regional Health Service, ASL Roma 1, Rome, Italy
hDepartment of Child and Adolescent Psychiatry/Psychology, Erasmus University Medical Centre–Sophia Children’s Hospital, Rotterdam, Netherlands
i Sorbonne Université, INSERM, Pierre Louis Institute of Epidemiology and Public Health, Epidemiology of Allergic and Respiratory Diseases Department (EPAR), Saint-
Antoine Medical School, Paris, France
j Institute for Advanced Biosciences (IAB), INSERM U1209, CNRS UMR 5309, Université Grenoble Alpes, 38000 Grenoble, France
k Biomax Informatics AG, Munich, Germany
lHopital Arnaud de Villeneuve University Hospital and Inserm, Montpellier, France
mDepartment of Social Medicine, Faculty of Medicine, University of Crete, Heraklion, Greece
n Preventive Medicine and Public Health Department, University of Basque Country (UPV/EHU), Spain
oHealth Research Institute-BIODONOSTIA, Basque Country, Spain
p Public Health Division of Gipuzkoa, San Sebastián, Spain
q Epidemiology and Environmental Health Joint Research Unit, FISABIO-Universitat Jaume I-Universitat de València, 46020 València, Spain
r Faculty of Nursing, University of Valencia, València, Spain
s Bradford Institute for Health Research, Bradford Royal Infirmary, Bradford, United Kingdom
t INSERM, U1168, VIMA: Aging and Chronic Diseases, Epidemiological and Public Health Approaches, Villejuif, France
uUniversité Versailles St-Quentin-en-Yvelines, UMR-S 1168, F-78180 Montigny le Bretonneux, France
vUniversité Rennes, INSERM, EHESP, Irset (Institut de recherche en santé, environnement et travail) – UMR_S 1085, F-35000 Rennes, France
A R T I C L E I N F O
Handling Editor: Hanna Boogaard
Keywords:
Air pollution
Asthma
Birth cohort
Pediatric
Eczema
Rhinoconjunctivitis
A B S T R A C T
Background: Uncertainly continues to exist regarding the role of air pollution on pediatric asthma and allergic
conditions, especially as air pollution levels have started to decrease in recent decades.
Objective: We examined associations of long-term air pollution levels at the home address with pediatric eczema,
rhinoconjunctivitis and asthma prevalences in five birth cohorts (BIB, EDEN, GASPII, RHEA and INMA) from
seven areas in five European countries.
Methods: Current eczema, rhinoconjunctivitis and asthma were assessed in children aged four (N = 6527) and
eight years (N = 2489). A multi-morbidity outcome (≥2 conditions versus none) was also defined. Individual
outdoor levels of nitrogen dioxide (NO2), nitrogen oxides, mass of particulate matter with an aerodynamic
diameter< 10 μm (PM10), 10–2.5 μm (PMcoarse) and< 2.5 μm (PM2.5), and PM2.5 absorbance were assigned to
the birth, four- and eight-year home addresses using highly defined spatial air pollution exposure models.
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T
Cohort-specific cross-sectional associations were assessed using logistic regression models adjusted for demo-
graphic and environmental covariates and combined in a random effects meta-analysis.
Results: The overall prevalence of pediatric eczema, rhinoconjunctivitis and asthma at four years was 15.4%,
5.9% and 12.4%. We found no increase in the prevalence of these outcomes at four or eight years with increasing
air pollution exposure. For example, the meta-analysis adjusted odds ratios (95% confidence intervals) for ec-
zema, rhinoconjunctivitis and asthma at four years were 0.94 (0.81, 1.09), 0.90 (0.75, 1.09), and 0.91 (0.74,
1.11), respectively, per 10 μg/m3 increase in NO2 at the birth address, and 1.00 (0.81, 1.23), 0.70 (0.49, 1.00)
and 0.88 (0.54, 1.45), respectively, per 5 μg/m3 increase in PM2.5 at the birth address.
Discussion: In this large meta-analysis of five birth cohorts, we found no indication of adverse effects of long-
term air pollution exposure on the prevalence of current pediatric eczema, rhinoconjunctivitis or asthma.
1. Introduction
Is long-term air pollution associated with the development and pre-
valence of asthma and related allergic conditions? Numerous studies
(especially for asthma) have attempted to answer this question, and
there are now six systematic reviews and meta-analyses that summarize
the existing evidence. Overall, the evidence for an association between
long-term air pollution exposure and asthma incidence and prevalence
is frequently considered as sufficient, with most (Anderson et al., 2013;
Bowatte et al., 2015; Favarato et al., 2014; Gasana et al., 2012; Khreis
et al., 2017) but not all (Heinrich et al., 2016) meta-analyses reporting
significant associations. Health impact assessment strategies are also
suggesting that air pollution may contribute to a significant burden of
childhood asthma cases (Khreis et al., 2019).
For other allergic diseases (e.g. rhinoconjunctivitis, eczema, sensi-
tization), there are substantially fewer studies and the evidence is less
strong. Most recently, one review (including studies up to March 2014)
reported sufficient evidence for an association (Bowatte et al., 2015),
but an extension of this effort (including studies from March 2014 to
January 2016) reported the evidence as insufficient to confirm a causal
association (Heinrich et al., 2016). In light of this uncertainty, further
longitudinal birth cohort studies with standardized exposure assess-
ment and outcome and confounder definitions are needed (Khreis et al.,
2017), ideally from different regions in Europe and covering a wide
range of exposure concentrations.
The “Mechanisms of the Development of Allergy (MeDALL)” (Benet
et al., 2019; Pinart et al., 2014) and “European Study of Air Pollution
Effects” (ESCAPE) collaborations have respectively yielded guidelines
to define allergic outcomes (agreed upon by international consensus)
and a standardized method of air pollution exposure assignment for
many European cohorts. A recent longitudinal study of four cohorts
which capitalized on these efforts found evidence to support an asso-
ciation with long-term air pollution exposure for asthma with an onset
after four years of age among 14–16-year-olds, whereas no associations
were found for rhinoconjunctivitis (Gehring et al., 2015). Despite the
many strengths of this large longitudinal effort, the exposure models
were based on air pollution measurement campaigns that coincided
with the most recent follow-ups of the cohorts, which adds uncertainty
in the assessment of historical exposures.
In this study, we examined whether long-term air pollution ex-
posure is associated with the prevalence of current eczema, rhino-
conjunctivitis and asthma in a large population of young children from
seven areas participating in five recent population-based birth cohorts.
These cohorts were selected as (1) they have outcomes defined ac-
cording to MeDALL-guidelines (although deviations exist at younger
ages), (2) they have available air pollution exposure models (created
using ESCAPE protocols or comparable methods) and importantly, (3)
these air pollution exposure models were developed using air pollution
monitoring data collected at the time of birth or during the first years of
life of the participants. Furthermore, although air quality limits con-
tinue to be regularly exceeded, the children participating in these co-
horts were born during a time when average levels of certain pollutants
were decreasing in Europe (e.g. population weighted concentrations of
PM2.5 in 1990 and 2015 were respectively 14 and 11 µg/m3 in the
United Kingdom, 16 and 13 µg/m3 in France, 21 and 18 µg/m3 in Italy
and Greece and 12 and 10 µg/m3 in Spain (Health Effects Insitute,
2019). The participants were thus presumably exposed to lower air
pollution levels than in earlier decades, and investigations as to whe-
ther adverse associations are also detectable at these lower air pollution
levels are required. Finally, we also a priori aimed to examine associa-
tions with having at least two health conditions (i.e. multi-morbidity),
which has not yet been considered in previous work but occurs more
often than expected by chance, suggesting the existence of shared
causal mechanisms (Pinart et al., 2014).
2. Materials and methods
2.1. Study population
Of the 14 European birth cohorts that participated in the MeDALL
collaboration (Benet et al., 2019), the five ongoing population-based
birth cohorts that fit our inclusion criteria and agreed to participate
were: the English Born In Bradford (BIB) cohort (recruited in Bradford)
(Wright et al., 2013), the French mother-child EDEN cohort (recruited
in Nancy and Poitiers) (Heude et al., 2016), the Gene and Environment:
prospective study on infancy in Italy cohort (GASPII) (recruited in
Rome) (Porta and Fantini, 2006; Porta et al., 2007), the mother-child
Greek RHEA cohort (recruited in the prefecture of Heraklion) (Chatzi
et al., 2009), and the Spanish INfancia y Medio Ambiente: Environment
and Childhood (INMA) network of birth cohorts (recruited in Gipuzkoa,
Sabadell and Valencia) (Guxens et al., 2012). For the latter INMA co-
hort, data from the three study areas were analyzed separately as dif-
ferent air pollution exposure models were developed for each area. A
comparison between the time of cohort recruitment and collection of
air pollution monitoring data is provided in Table 1. Approval by the
local ethics committees and written consent from the participants’ fa-
milies were obtained by all cohorts. The cohorts are further described in
the Supplemental Material, Participating cohorts section.
Table 1
Comparison of year of cohort recruitment and air pollution measurement
campaign.
Cohort Cohort recruitment Collection of air pollution monitoring
data
BIB 2007–2011 01-06-2009–15-12-2009
EDEN 2003–2006 2002–2005
GASPII 2003–2004 27-01-2010–26-01-2011
RHEA 2007–2008 18-02-2009–16-02-2010
INMA-Gipuzcoa 2006–2008 03-02-2009–15-07-2009 (NO2 and NOx)
2006–2007 (PM2.5)
INMA-Sabadell 2004–2006 14-01-2009–14-01-2010
INMA-Valencia 2003–2005 17-02-2009–23-07-2009 (NO2 and NOx)
02-2005–06-2005 (PM2.5)
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2.2. Outcomes
The three main outcomes in this analysis were current eczema,
current rhinoconjunctivitis and current asthma. All three health out-
comes were available for nearly all sites at the age of four years (INMA-
Sabadell had no information on eczema) whereas only five of the seven
sites had outcome data at age eight years (BIB and RHEA did not have
data available). Of note, participants in INMA-Sabadell were closer to
age seven years. As much as possible, the health outcomes were defined
following the phenotypic definitions proposed by the MeDALL con-
sortium (Benet et al., 2019; Pinart et al., 2014). Small deviations from
the proposed MeDALL definitions do exist for the GASPII and INMA
cohorts at age four years only, as summarized in the Supplemental
Material (Table S1).
Current eczema was defined as positive answers to both:
• Has your child had an itchy rash which was coming and going (in-
termittently) at any time in the past 12 months?; and• Has this itchy rash at any time affected any of the following places:
the folds of the elbows, behind the knees, in front of the ankles,
under the buttocks, or around the neck, ears or eyes.
Current rhinoconjunctivitis was defined as positive answers to both
• In the past 12 months, has your child had problems with sneezing or
a runny or blocked nose when he/she did not have a cold or flu?,
and• If yes, in the past 12 months, has this nose problem been accom-
panied by itchy-watery eyes?
Current asthma was defined as a positive answer to at least two of
the three following questions:
• Has your child had wheezing or whistling in the chest in the past
12 months?• Has your child ever been diagnosed by a doctor as having asthma?• Has your child taken any medicines for asthma or breathing diffi-
culties (wheezing, chest tightness, shortness of breath) in the last
12 months?
A secondary multi-morbidity outcome was also calculated, defined
as having at least two of three conditions versus having none. This
outcome was only defined for areas and ages for which information on
eczema, rhinoconjunctivitis and asthma were all available (all cohorts
except INMA-Sabadell at four years and BIB and RHEA at eight years).
Note that in this analysis, all outcomes required that symptoms/
medications be present “in the last 12 months” and hence we modelled
the prevalence of current “active” conditions and not the incidence of
disease. This decision is supported by the low number of incident cases
between four and eight years of age per cohort and because not all
cohorts had repeated outcome and air pollution data.
2.3. Exposure assignment
For nearly all cohorts, long-term (annual average) concentrations of
nitrogen dioxide (NO2), nitrogen oxides (NOx), mass of particulate
matter with an aerodynamic diameter< 10 μm (PM10), between 10 μm
and 2.5 μm (PM coarse) and< 2.5 μm (PM2.5), as well as PM2.5 ab-
sorbance were estimated to each participant’s home address at birth
and at the time of outcome assessment (four and eight years) using
land-use regression (LUR) models developed following ESCAPE proto-
cols (Beelen et al., 2013; Cyrys et al., 2012; Eeftens et al., 2012a,
2012b). Briefly, as part of the ESCAPE study, three two-week air pol-
lution monitoring campaigns were performed at chosen sites in the
study areas. Site-specific annual averages were calculated using the
average of these three measurement periods and were adjusted for
temporal variation using data from a centrally located background re-
ference site which operated continuously throughout the measurement
year. Area-specific LUR models were developed, which relate these site-
specific measured annual average concentrations to predictor variables
derived from Geographic Information Systems through a supervised
stepwise multivariable linear regression.
The ESCAPE exposure methodology was used to estimate NO2 and
NOx levels in all cohorts, except in EDEN, for which NO2 was estimated
using a local dispersion model (AIRLOR, 2010; Galineau et al., 2011).
For PM10, PM2.5, PM coarse and PM2.5 absorbance, ESCAPE area-spe-
cific LUR models existed for four sites only (BIB, RHEA, GASPII and
INMA-Sabadell). For EDEN, PM2.5 levels were instead estimated using
an existing European-wide LUR model (Wang et al., 2014). This Eur-
opean-wide LUR model was developed by combining all data collected
in the 17 European areas that participated in ESCAPE and can be ap-
plied to areas that did not collect particulate matter samples and where
the main source of PM2.5 is road traffic. The study area of INMA-Gi-
puzkoa is characterized by low road traffic intensity but a high metal-
industry pressure (Lertxundi et al, 2010), and thus, PM2.5 levels were
derived as the average measured PM2.5 concentration from the closest
monitoring site to each participant’s address during the entire preg-
nancy period (Lertxundi et al., 2010, 2015). For INMA-Valencia, PM2.5
levels were assigned using inverse distance weighting based on data
collected from five monitoring stations during the pregnancy period of
the participants. For these latter two cohorts (INMA-Gipuzkoa and
INMA-Valencia), PM2.5 levels were also available from the European-
wide LUR model described above (Wang et al., 2014) and these esti-
mates were used in a sensitivity analysis. A summary of the availability
and associated methodological references of the air pollutants is pro-
vided in the Supplemental Material (Table S2).
For nearly all cohorts, the home address at the time of birth was
used to assign exposures early in life (birth exposures). However, for
EDEN, the address given at the third trimester was used, and for INMA-
Valencia, the address that the mother reported spending the most time
at during her pregnancy was used. To assign the air pollution exposure
levels later in life (current exposures), we used the home addresses
given at the four-year and eight-year follow-ups (see Supplemental
Material, Table S2).
2.4. Statistical analysis
Logistic regression models were used to analyze cross-sectional as-
sociations of air pollution exposure with the prevalence of each out-
come at each age. We conducted separate analyses for air pollution
estimated to the birth address (birth exposure) and to the address at
each time of follow-up (current exposure). We analyzed cohort-specific
associations and subsequently combined them in a random-effects
meta-analysis to allow for potential heterogeneity between study areas
(Basagaña et al., 2018), using the “meta” package in the statistical
software R (Schwarzer, 2007). Following recommendations, we con-
ducted a meta-analysis when a minimum of two cohorts were available
(Valentine et al., 2010). The percentage variability between the studies
that is present beyond what would be expected by chance is described
using the I2 statistic (Higgins and Thompson, 2002). A test for hetero-
geneity of effect estimates between cohorts was conducted. Prediction
intervals (95%), which represent the range of true effects that can be
expected for 95% of similar future settings (Borenstein et al., 2017;
IntHout et al., 2016), are also reported for meta-analyses using data
from at least three cohorts.
Air pollution exposures were entered as continuous variables
without transformation. Odds ratios (ORs) and their 95% confidence
intervals are presented per 10 µg/m3 NO2, 20 µg/m3 NOx, 10 µg/m3
PM10, 5 µg/m3 PM2.5 and PM coarse and 1 10−5/m PM2.5 absorbance.
Models were adjusted for the following covariates selected a priori to
match those in recent ESCAPE and MeDALL studies (Gehring et al.,
2015; Mölter et al., 2014): maternal and paternal asthma and hay fever,
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4
maternal and paternal education, breastfeeding, older siblings, daycare
attendance during first year of life, maternal smoking during preg-
nancy, parental smoking at home during early-life, mould or dampness
at home during early-life, furry pets in the home during early-life and
use of gas for cooking during early-life. Use of gas for cooking was not
included in the models in RHEA (data not collected) and GASPII (99.5%
prevalence of use of gas for cooking), nor was daycare attendance and
furry pet ownership included in the models in BIB (data not collected
for a large proportion of this cohort). Native nationality was not in-
cluded as a covariate due to large differences in the way these data were
collected across cohorts.
Sensitivity analyses included (1) using a pooled analysis approach
with a fixed adjustment for center, (2) adjusting for birth weight, which
may lie in the causal pathway, (3) excluding those born prematurely
(< 37 weeks gestational age, N = 437) who may be at increased risk,
(4) removing the adjustment for parental allergy which may represent
an over-adjustment, (5) excluding cohorts/air pollutants that were es-
timated using methods not strictly adhering to ESCAPE protocols, (6)
replicating the meta-analysis for PM2.5 mass using estimates from the
European-wide LUR model (Wang et al., 2014) for INMA-Gipuzkoa and
INMA-Valencia and testing for effect modification by (7) sex and (8)
whether or not the child had moved since birth using interaction terms
and stratification analyses. The models stratified by sex and moving
status, as well as those run on the multi-morbidity secondary outcome,
Fig. 1. Distribution of pollutants per cohort at the birth address. The horizontal dark line represents the median. The ends of the grey box show the upper and lower
quartiles.
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were only adjusted for maternal and paternal asthma and hay fever,
smoking during pregnancy and parental smoking at home during early-
life because of problems with model singularities when additional
covariates were included, attributable to the small number of cases in
certain strata. Finally, we also analyzed the three components of the
asthma outcome definition separately (wheezing, medication and
asthma doctor diagnosis) as the practice of providing a clinical diag-
nosis of asthma at young ages may vary by country.
3. Results
After restricting the data to those with available health and air
pollution data at any time point, 6856 participants were available for
analysis (6527 and 2489 at age four and eight years, respectively). The
characteristics of this study population are presented in Table 2. The
mean age at the four-year follow-up was narrowly around four years for
all cohorts, whereas that at the eight-year follow-up was more varied
(mean age was 6.7 years in INMA-Sabadell and 8.1 years in EDEN).
Eczema prevalences ranged from 4.7% at eight years in GASPII to
24.4% at four years in INMA-Gipuzkoa. Rhinoconjunctivitis pre-
valences ranged from 1.9% at four years in INMA-Sabadell to 9.7% at
eight years in EDEN. Asthma prevalences ranged from 3.8% at four
years in GASPII to 15.7% at four years in both BIB and INMA-Sabadell.
Multi-morbidity prevalences were lowest in GASPII (2.2% at eight
years) and highest in BIB (9.4% at four years).
The distribution of the air pollutants estimated to the birth (Fig. 1),
four- (Supplemental Material, Fig. S1) and eight-year (Supplemental
Material, Fig. S2) home addresses are presented per cohort. For NO2
and NOx (only available for 6/7 cohorts), the levels and range of pol-
lutants estimated to the birth address were highest in GASPII, INMA-
Sabadell and INMA-Valencia. For PM2.5 estimated to the birth address,
concentrations were highest in GASPII and INMA-Valencia.
Pollutants estimated to the same addresses tended to be moderately
to highly correlated in most cases (Table S3). However, lower correla-
tions were observed between PM2.5 with NO2 and NOx in INMA-
Gipuzkoa and INMA-Valencia. Among those who moved during the
study, there was no consistent pattern in the correlations between the
air pollutants estimated to the birth address and those estimated to the
four- and eight-year addresses (Table S4).
The meta-analytic adjusted associations for the air pollutants esti-
mated to the birth and current addresses are presented in Tables 3 and
4, respectively (forests plots are presented in the Supplemental Mate-
rial, Figs. S3–S14). Overall, there was no indication of an increase in
prevalence of any of the outcomes in association with higher levels of
any of the pollutants. Only for the associations between asthma at age
eight years and the pollutants estimated to the current (eight year)
addresses were the ORs consistently greater than one, although no as-
sociation reached statistical significance. When considering each of the
three components of the asthma outcome definition separately
(wheezing, medication and asthma doctor diagnosis, presented in Table
S5 and Table S6 for ages four and eight years, respectively), ORs were
only greater than one for ever having a doctor diagnosis of asthma by
age eight years (Table S6).
In the adjusted models for asthma at four years, there was moderate
(I2 between 30 and 50%) heterogeneity between the cohort-specific
effect estimates for NO2 estimated to the birth and current addresses
and the heterogeneity was more marked (I2 > 50%) for PM2.5 esti-
mated to the birth and current addresses. Heterogeneity was also ob-
served for both rhinoconjunctivitis and asthma at eight years for nearly
all pollutants estimated to the birth address and for rhinoconjunctivitis
at eight years when pollutants were estimated to the current address.
No association was found between any air pollutant and the sec-
ondary multi-morbidity outcome (Table S7). Throughout all sensitivity
analyses, we found no evidence to indicate the existence of an asso-
ciation between any of the air pollutants and the outcomes (Tables S8
and S9 for the health outcomes at ages four and eight, respectively, for
sensitivity analyses (1) to (4)). Excluding cohorts/air pollutants that
were estimated using methods not strictly adhering to ESCAPE proto-
cols and replicating the meta-analysis for PM2.5 mass using estimates
from the European-wide LUR model for INMA-Gipuzkoa and INMA-
Valencia also did not change the findings.
All interaction terms between sex and the air pollutants as well as
moving status and the air pollutants were non-significant (p > 0.05).
Associations stratified by sex are presented in the Supplemental
Material (Table S10) as are analyses restricted to never-movers for the
air pollutants estimated to the birth address (to decrease exposure
misclassification) and movers for the air pollutants estimated to the
current address (Table S11).
4. Discussion
Using all available data from five birth cohorts covering seven areas
in Europe, we found no evidence to support the hypothesis that long-
term air pollution levels estimated to the home address are associated
with an increased prevalence of current pediatric eczema, rhino-
conjunctivitis or asthma. Results remained null throughout all sensi-
tivity analyses conducted, including stratification by sex and moving
behaviour.
4.1. Comparisons with the literature
Previous studies conducted using individual-level data in Western
countries have yielded inconsistent evidence for a role of air pollution
on eczema and rhinoconjunctivitis. For eczema, some studies report
adverse associations for specific exposure-outcome combinations
(Brunekreef et al., 2009; Krämer et al., 2009; Morgenstern et al., 2008;
Pénard-Morand et al., 2010), whereas others report overall null find-
ings (Aguilera et al., 2013; Gehring et al., 2010), such as a recent large
pooled analysis of 5685 children (aged up to eight years) from six birth
cohorts (Hüls et al., 2018). For rhinoconjunctivitis, differences across
ages (Fuertes et al., 2013; Morgenstern et al., 2008) have been noted or
associations appear restricted to population subgroups (e.g. those living
in urban areas in Germany (Krämer et al., 2000) or non-movers in the
Dutch PIAMA cohort (Gehring et al., 2010)). The largest most recent
analysis on rhinoconjunctivitis (on 14,126 participants aged
14–16 years-old from four birth cohorts) found no indication of an
adverse effect of air pollution (Gehring et al., 2015). In contrast, a re-
cent meta-analysis of five cohort studies (all based in Asia) which ex-
plicitly used the term “allergic rhinitis” concluded an adverse effect of
air pollution (Zou et al., 2018). However, given the small number of
studies considered, the results of this latter work are unlikely to be
generalizable. In general, the lack of associations observed in the cur-
rent study for eczema and rhinoconjunctivitis are in line with the
overall body of scientific literature, which does not suggest a strong,
robust impact of air pollution on these outcomes.
It is more difficult to reconcile the observed null findings for asthma
with the existing literature, as most (Bowatte et al., 2015; Khreis et al.,
2017) but not all (Heinrich et al., 2016) recent efforts summarizing
published studies support an adverse role of air pollution in asthma. It is
nonetheless interesting that our overall null findings are in line with the
large cross-sectional meta-analysis of five birth cohorts (MAAS, BAMSE,
PIAMA, GINIplus and LISAplus, N = 17,041) conducted as part of the
ESCAPE collaboration, in which asthma at age four and eight years was
analyzed (Mölter et al., 2014). Only when four (of these five) cohorts
were re-analyzed longitudinally (including data up to 14–16 years of
age, N = 14,126) were adverse associations apparent, and primarily for
asthma with an onset after four years of age (Gehring et al., 2015, e.g.
meta-analyzed OR for the association between NO2 and incident asthma
up to 14–16 years was 1.13 (1.02, 1.25) per 10 µg/m3). Gehring et al.,
2015 suggest that asthma may be more easily diagnosed at older ages,
which would reduce outcome misclassification and the (likely) re-
sulting non-differential bias. When present, this bias would drive
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associations towards the null. A similar observation was made in the
Swedish BAMSE birth cohort, in which associations between NOx and
PM10 during the first year of life were only apparent for prevalent
asthma at 12 years (1.66 (1.01, 2.72) per 46.8 µg/m3 increase and 1.96
(1.08, 3.53) per 7.2 µg/m3 increase, respectively, N = 4089) but not at
younger ages (Gruzieva et al., 2013).
It is indeed intriguing that in the current study, the ORs were most
consistently greater than one for associations with asthma at age eight
years using both the MeDALL-based outcome definition (Table 4) and
the single question on ever doctor diagnosis (Supplemental Material,
Table S6). However, given the number of tests conducted and the more
limited number of cohorts contributing data to these models, these
results should be interpreted with caution.
It should be noted that although a high percentage of European
urban populations continue to be exposed to levels that exceed
European Union and World Health Organization reference levels, air
pollution levels in general have decreased in Europe during the last
decades (Colette et al., 2017; Guerreiro et al., 2014). Hence the children
included in the current analysis, who are participating in more recently
established birth cohorts, would likely have been exposed to lower
average levels of air pollution than in earlier decades. Ultimately, we
can only speculate regarding the reasons behind the lack of consistent
associations with asthma, but it is possible that a future re-analysis of
the participating cohorts, in which repeated and longitudinal data are
available on asthma at older ages, could yield different results.
4.2. Strengths and limitations
This analysis included all available data from several large pro-
spective well characterized birth cohorts, which allowed adjustments
for many early-life and current known risk factors for asthma and al-
lergic diseases. We chose to adjust the models for the same covariates as
used in a previous similar analysis (Gehring et al., 2015) to increase the
compatibility of our results. Unfortunately, because of the lack of ex-
isting data in most cohorts, we were unable to adjust for area-level
socioeconomic variables (although maternal and paternal education
were included as markers of individual-level socioeconomic status),
consider gene-environment interactions (for which the epidemiological
evidence is strongest for asthma (e.g. (MacIntyre et al., 2014)), or
stratify the associations by atopic status (for which there is growing
evidence that air pollution may be more strongly associated with non-
allergic asthma compared to allergic asthma (Khreis et al., 2017)).
Participation bias, a near universal concern for cohorts with long
follow-ups, and the fact that each cohort has its own respective char-
acteristics may affect the generalizability of the results (e.g. BIB is
composed of a deprived multi-ethnic population (Wright et al., 2013),
13% of the RHEA cohort was born prematurely, attrition in the INMA
and GASPII cohorts appears linked to lower socioeconomic markers
(Guxens et al., 2012; Porta et al., 2007)). However, it is notable that no
consistent association for any air pollutant - health outcome combina-
tion was observed in any cohort (forest plots provided in the Supple-
mental Material, Figs. S3–S14). This confirms that the overall null meta-
analytic results are not driven by the results from a single cohort.
Despite using all available data, we chose to model disease pre-
valence instead of incidence due to an insufficient number of incident
cases between four and eight years of age per cohort (e.g. range of
11–38 new asthma cases in GASPII and EDEN, respectively) and be-
cause our outcome definitions required symptoms/medications “in the
last 12 months”, which is indicative of prevalent “active” disease.
Similarly, as not all cohorts had repeated outcome and air pollution
data, we pursued cross-sectional analyses instead of longitudinal ana-
lyses to maximize the use of all available data. As such, the analyses
presented here suggest there may be no associations between air pol-
lution exposure and childhood asthma, rhinoconjunctivitis or eczema
prevalence, but are unable to inform on the role of air pollution on the
development of these conditions.
As much as possible, we used the outcome definitions proposed by
the MeDALL collaboration. However, because much of the health data
at four years were collected prior to MeDALL, there are differences in
how the outcomes were defined at age four years only (summarized in
Table S1), which may affect the comparison of outcome prevalences
across cohorts and ages. Furthermore, even when the same wording was
used, there are likely differences in country-specific practices related to
providing a clinical asthma diagnosis, especially at four years. Wide
differences in the prevalence of asthma, rhinoconjunctivitis and eczema
have been documented in children in large global studies using iden-
tical questionnaires (Aït-Khaled et al., 2009; Lai et al., 2009; Odhiambo
et al., 2009). Given the null findings we observed for air pollution, the
main determinants of this variability in disease prevalence remain un-
defined but are likely related to local environmental or ecologic factors,
and probably reflect differences in language, socioeconomic develop-
ment, lifestyle, culture, education, medical practice and health concepts
(Mallol et al., 2013). Finally, the extensive available health data al-
lowed us to examine associations with multi-morbidity, which has not
yet been reported in relation to air pollution using large cohort studies.
Most air pollutants were estimated to the home addresses using
area-specific LUR models developed following ESCAPE protocols. An
exception to this was that PM2.5 was assigned using a single European-
wide LUR model in EDEN (Wang et al., 2014). Previous work has found
the application of this European-wide LUR model to areas not used in
its development to be a reasonable approach, although the precision of
the effect estimates may be reduced (Wang et al., 2014). Furthermore,
PM2.5 was assigned using average measurements from the nearest
monitor in INMA-Gipuzkoa and distance inverse weighting methods in
INMA-Valencia. These differences in exposure methodology may be one
reason why the correlations between PM2.5 with NO2 and NOx were
quite low in these two study areas. However, the results did not change
when excluding EDEN, INMA-Gipuzkoa and INMA-Valencia from the
meta-analysis for PM2.5 mass, using the European-wide LUR model
PM2.5 mass estimates (Wang et al., 2014) for INMA-Gipuzkoa and
INMA-Valencia, or excluding EDEN from the analyses with NO2, which
was the only area which did not use the ESCAPE LUR models to assign
NO2 exposure levels.
Despite these differences in exposure assessment, this study is no-
table in that the monitoring data used to inform the development of the
air pollution exposure models were collected at (four areas) or near
(within four to seven years, three areas) the time of birth of the parti-
cipants. As such, the years in which monitoring data were collected
differs by cohort. This likely reduced some exposure misclassification
for the air pollutants estimated to the home address at birth, as there is
no need to assume that the spatial distribution of the air pollution
sources (large roads, land use patterns, industrial areas) and their as-
sociated pollutants has not changed between the birth of a participant
and the time the monitoring data were collected. However, it is still
necessary to make this assumption for the air pollutants estimated to
the four and eight-year home addresses and thus the potential for ex-
posure misclassification is likely greater at these later time points.
Associations with these latter air pollution exposures are also more
likely to be at risk of reverse causation (i.e. families of asthmatic chil-
dren being more likely to move to areas of low air pollution), although
we did not find that those with asthma or allergic diseases were more
likely to move throughout the follow-up.
Additional sources of potential exposure misclassification include
that we did not consider exposures that occurred away from the home
(at daycares/schools, during commuting), although previous studies
have found exposures at the home address to be good approximations of
those at schools (Gruzieva et al., 2012; Reungoat et al., 2005). We also
did not consider all potential outdoor pollutants that may influence
health, such as ozone levels (Sousa et al., 2013). The effects of NO2 and
ozone have been shown to be underestimated in single-pollutant ana-
lyses when these pollutants are highly negatively correlated (Janssen
et al., 2017). We were also unable to consider indoor air pollution
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exposures (and those with asthma or other respiratory disorders may
exhibit different indoor and outdoor time-activity patterns), the com-
position of particulate matter (which can vary significantly over geo-
graphical areas (Götschi et al., 2005) and may be as or more important
for health than particulate matter concentrations (Traversi et al.,
2009)), and many other unknown and unmeasured factors within an
individual's exposome that may be related to asthma and allergic dis-
eases (Cecchi et al., 2018). Finally, we chose not to pursue multi-
pollutant models as we found no evidence of associations in any of the
single pollutant models.
In conclusion, using observational data from seven areas partici-
pating in five European birth cohorts, we found no evidence to suggest
that long-term air pollution levels are associated with the prevalence of
current pediatric eczema, rhinoconjunctivitis or asthma up to age eight
years. Future follow-ups of these cohorts using large-scale cross-cohort
analyses are needed to determine whether adverse associations may
become apparent at older ages, particularly for asthma. Despite the
observed null findings, policies and actions promoting a reduction in air
pollution should continue given the relatively strong evidence for ad-
verse effects of air pollution on numerous other health outcomes.
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